San Diego, CA -- (SBWIRE) -- 12/14/2017 -- The Shareholders Foundation announces that an investor, who purchased NASDAQ:ALKS shares, filed a lawsuit against Alkermes in the U.S. over alleged violations of Federal Securities Laws by Alkermes Plc.

Investors who purchased shares of Alkermes Plc (NASDAQ:ALKS) should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The plaintiff claims that between February 24, 2015, and November 3, 2017, the Defendants made false and/or misleading statements and/or failed to disclose that Alkermes systemically engaged in deceptive marketing campaigns to influence policymakers to use Vivitrol in addiction treatment programs over more scientifically proven and efficacious alternatives, that the foregoing conduct, when disclosed, would foreseeably subject Alkermes to heightened regulatory and legislative scrutiny, that accordingly, the Company's revenues derived from Vivitrol during the Class Period were unsustainable, and that as a result of the foregoing, Alkermes shares traded at artificially inflated prices between February 24, 2015, and November 3, 2017, and class members suffered significant losses and damages.

Those who purchased shares of Alkermes Plc (NASDAQ:ALKS) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com